Skip to main content
TipRanks
Go Ultimate75% OFF

Compare MannKind (MNKD) vs. Competitors

2,105 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
MNKDMannKind$4.16$1.35B-17.60-20.76%Strong BuyUnlock the MNKD analyst price target with TipRanks PremiumMNKDUnlock the MNKD top-analyst price target with TipRanks Premium
LXRXLexicon Pharmaceuticals$1.82$832.59M-12.5518.18%Strong BuyUnlock the LXRX analyst price target with TipRanks PremiumMNKD vs LXRXUnlock the LXRX top-analyst price target with TipRanks Premium
INVAInnoviva$18.97$1.34B7.45-14.86%Strong BuyUnlock the INVA analyst price target with TipRanks PremiumMNKD vs INVAUnlock the INVA top-analyst price target with TipRanks Premium
SVRASavara$4.72$1.10B-7.8214.56%Strong BuyUnlock the SVRA analyst price target with TipRanks PremiumMNKD vs SVRAUnlock the SVRA top-analyst price target with TipRanks Premium
XERSXeris Pharmaceuticals$16.65$3.02B-413.43119.37%Strong BuyUnlock the XERS analyst price target with TipRanks PremiumMNKD vs XERSUnlock the XERS top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
MNKDMannKind4.16-0.90-17.79%
LXRXLexicon Pharmaceuticals1.820.3322.15%
INVAInnoviva18.97-3.28-14.74%
SVRASavara4.720.429.77%
XERSXeris Pharmaceuticals16.659.47131.89%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts